The feasibility of using visible fluorimetry as a simple spectroscopic
method for cancer diagnosis and/or management was investigated by rec
ording the visible fluorescence emission spectra of sera from cancer p
atients and healthy individuals. Characteristic visible fluorescence e
mission spectra were found to occur in sera of some cancer patients, e
.g., patients with breast or lung cancer, with spectral features simil
ar to those observed among porphyrin and porphyrin-related compounds.
Possible physico-chemical factors responsible for the occurrence of th
ese unique visible fluorescence features among cancer patients were br
iefly discussed.